Nature Communications (Jun 2022)

Peripherally restricted transthyretin-based delivery system for probes and therapeutics avoiding opioid-related side effects

  • Md Tariqul Haque Tuhin,
  • Dengpan Liang,
  • Fang Liu,
  • Hala Aldawod,
  • Toufiq Ul Amin,
  • Joshua S. Ho,
  • Rasha Emara,
  • Arjun D. Patel,
  • Melanie A. Felmlee,
  • Miki S. Park,
  • James A. Uchizono,
  • Mamoun M. Alhamadsheh

DOI
https://doi.org/10.1038/s41467-022-31342-z
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 15

Abstract

Read online

The current peripherally acting mu-opioid receptor antagonists present limited permeability and pharmacokinetic properties. Here, the authors develop a drug delivery approach based on AG10, which demonstrates the impact of mu-opioid receptors in the central nervous system in precipitating opioid-induced constipation.